Max Nieuwdorp

Plain English
This study looked at how the bacteria in our gut affect our chances of getting seriously ill from COVID-19. Researchers analyzed samples from over 5,000 people and found that those with more butyrate-producing bacteria had a lower risk of hospitalization and death from severe COVID-19. This is important because it suggests that maintaining a healthy gut microbiome could help prevent serious COVID-19 cases. Who this helps: This helps patients and healthcare providers in focusing on gut health as a way to reduce the risk of severe COVID-19.

Plain English
This study looked at two types of biopsies—bone biopsies and ulcer bed biopsies—to see which one was better for deciding antibiotic treatment for diabetic foot osteomyelitis (DFO). After 12 months, 31.4% of patients treated based on bone biopsies were in remission, while 39.4% of those treated based on ulcer bed biopsies achieved remission. The findings show that bone biopsies do not provide any significant advantage over ulcer bed biopsies for treating this condition. Who this helps: This benefits patients with diabetic foot osteomyelitis and their doctors by simplifying treatment decisions.

Plain English
This study looked at the effects of butyrate, a substance produced by gut bacteria, on depression. Researchers found that while a 1-week treatment with butyrate did not change mood in healthy men, it did reduce depressive and anxiety symptoms in patients with ulcerative colitis after 12 weeks. Overall, animal studies suggested that butyrate might help with depression through various mechanisms, indicating that it could be a promising new treatment option. Who this helps: This helps patients dealing with depression, particularly those with gastrointestinal issues.

Plain English
This study looked at how the gut bacteria we have early in life help develop our immune systems, and how changes to these bacteria can lead to autoimmune diseases like type 1 diabetes and inflammatory bowel disease. It found that factors like cesarean delivery and antibiotic use can disrupt the healthy bacteria that are important for immune health, which is linked to a higher risk of these diseases in children. Understanding this connection can help in finding ways to prevent autoimmune diseases by improving gut bacteria in newborns. Who this helps: This benefits patients, especially newborns and young children at risk of autoimmune diseases.

Plain English
This study looked at the amount of artery plaque in people with type 1 diabetes compared to healthy individuals. It found that 31% of those with diabetes had significant plaque, which is similar to the 22% seen in healthy participants, indicating that both groups had comparable risks for heart disease. This is important because it suggests that people with type 1 diabetes, even if well-managed, still need close monitoring and proactive treatment to prevent cardiovascular problems. Who this helps: This helps patients with type 1 diabetes and their doctors.

Plain English
This study looked at how combining weight-loss surgeries, like endoscopic sleeve gastroplasty, with anti-obesity medications or probiotics affects weight loss. It found that using GLP-1 receptor agonists (a type of anti-obesity medication) with these surgeries can lead to better weight loss results. For instance, patients who struggled with losing weight after surgery saw significant short-term results, while the effects of probiotics were minimal and inconsistent. Who this helps: This benefits patients struggling with obesity, especially those who have undergone weight-loss surgery but are not achieving desired results.

Plain English
This study examined abdominal pain in patients after bariatric surgery, a weight-loss surgery that helps treat severe obesity and related health issues like type 2 diabetes. Researchers found that between 33.8% and 54.4% of patients reported abdominal pain, which could not always be explained by common issues like gallstones or ulcers. The shifts in gut bacteria after surgery might contribute to this unexplained pain, indicating a need for further understanding of the relationship between gut health and post-surgery complications. Who this helps: This information helps patients and doctors manage and understand potential complications after bariatric surgery.

Plain English
This study focused on how SGLT inhibitors, a type of medication, affect the heart and kidneys, particularly looking at their mechanisms of action. By reviewing 24 previous studies involving 1,296 participants, the researchers aimed to find consistent patterns in how these medications work, specifically measuring kidney function using a precise method known as glomerular filtration rate (mGFR). The findings are important because they will help clarify how SGLT inhibitors benefit people, leading to better treatment options for heart and kidney diseases. Who this helps: This helps patients with heart and kidney conditions, as well as their doctors.

Plain English
This study looked at how specific gut bacteria are linked to heart and metabolic diseases over time in a diverse group of nearly 5,000 people. Researchers found that participants with more of a certain type of gut bacteria, Eubacterium xylanophilum, had a lower risk of serious heart-related events, while those with a different bacteria, Ruminococcus gnavus, had a higher risk. The results indicate that the balance of gut bacteria can impact long-term heart health and metabolic conditions. Who this helps: This helps patients at risk for heart disease and diabetes, as well as their healthcare providers.

Plain English
This study looks at how the bacteria in our gut might help in treating obesity and a condition called cancer cachexia, where patients lose weight and muscle despite eating. Researchers found that gut bacteria can influence important body processes related to energy and metabolism, and targeted treatments like probiotics or gut transplants could be a new way to help. This matters because current treatments for these conditions often don't work well, and finding better strategies can improve patients' quality of life. Who this helps: This helps patients struggling with obesity and cancer cachexia.

Plain English
This research studied a liver disease called metabolic dysfunction-associated steatotic liver disease (MASLD) and how well a type of MRI, combined with other tests, can detect its stages. They found that quantitative MRI is effective at diagnosing and staging MASLD, achieving a high accuracy rate of 83%, but adding extra tests didn't significantly improve the results. This research is important because it showcases a non-invasive method that could help doctors diagnose liver conditions earlier and provide better treatment options for patients. Who this helps: This helps patients with liver disease and their doctors.

Plain English
This research studied how to improve the process of collecting tissue samples from the duodenum (a part of the small intestine) to better understand the effects of a treatment called duodenal ablation on type 2 diabetes (T2D) and metabolic syndrome. The researchers tested a new method using cold snare resections on 9 patients and found that 80% of the tissue samples were well-oriented and suitable for further study. Additionally, 92% of samples from another study achieved high-quality tissue for analysis, confirming that this approach is safe and can support important research into the effects of treatments for T2D. Who this helps: This benefits patients with type 2 diabetes and metabolic syndrome by improving the understanding of their treatments.

Plain English
This study looked at the effects of a high-intensity exercise program on patients with metabolic dysfunction-associated steatotic liver disease (MASLD) and its active form, metabolic dysfunction-associated steatohepatitis (MASH). In 15 patients who did the exercise program for 12 weeks, cardiorespiratory fitness improved by 10.1%, and changes in fat and muscle metabolism were observed, but there were no significant improvements in liver health measures like fat content or liver fibrosis. These findings help clarify how exercise impacts the metabolism and health of patients with MASLD, indicating that more research is needed to determine the best exercise strategies for treating this condition. Who this helps: This benefits patients with MASLD and healthcare providers.

Plain English
This study looked at how a substance produced by gut bacteria called imidazole propionate (ImP) affects blood vessel cells and contributes to heart disease. Researchers found that higher levels of ImP in 831 patients were linked to an increased risk of coronary artery disease, and in laboratory tests, ImP harmed the function and repair abilities of blood vessel cells, leading to larger areas of clogged arteries in mice. This is important because it highlights a new way that gut bacteria might influence heart health and suggests that targeting ImP could provide a new treatment avenue for cardiovascular disease. Who this helps: This helps patients at risk for heart disease and doctors seeking new treatment options.

Plain English
This study looked at how moving from rural Ghana to urban areas and then to Amsterdam changed the gut bacteria in 1,177 Ghanaian people. Researchers found that as people migrated, their gut bacteria shifted significantly, with those in Amsterdam having different types and amounts of bacteria compared to those in rural Ghana. These changes were linked to increased risks for health issues like higher body weight, blood sugar levels, and blood pressure, highlighting the importance of gut health for people who migrate. Who this helps: This benefits migrants and healthcare providers working with them.

Plain English
This study examined how two diabetes medications, empagliflozin and linagliptin, affect kidney function in overweight people with type 2 diabetes during both fasting and after meals. Researchers found that empagliflozin significantly reduced kidney filtration rates both when fasting and after eating, while linagliptin did not have the same impact. These findings highlight that empagliflozin can improve kidney health in people with diabetes, which is important for preventing long-term complications related to kidney function. Who this helps: This benefits patients with type 2 diabetes, especially those concerned about their kidney health.

Plain English
This study looked at how a specific beneficial microbe, known as CH-106, affects blood sugar and heart health in adults at risk for type 2 diabetes. Over three months, those taking CH-106 saw a 6% improvement in blood sugar control and a 3 mm Hg drop in diastolic blood pressure, while experiencing no negative side effects. These findings are important because they suggest that this microbe could help manage health risks associated with diabetes. Who this helps: This benefits prediabetic patients and potentially reduces their risk of developing type 2 diabetes.

Plain English
This paper examines how bariatric surgery affects the gut bacteria of people who are obese. The researchers found that after surgery, like Roux-en-Y gastric bypass, there are notable changes in gut bacteria that relate to improvements in health markers, including better hormone levels and metabolism. Specifically, some beneficial gut bacteria increase significantly, which may indicate better metabolic health. Who this helps: Patients undergoing bariatric surgery.

Plain English
This study looked at how to identify a serious liver condition called metabolic dysfunction-associated steatohepatitis (MASH) without needing an invasive liver biopsy. Researchers tested blood samples from 86 patients and found that certain lipid levels in the blood, like desmosterol and phosphatidylcholine, were significantly higher in patients with MASH than those with earlier stage liver disease (MASL). These findings may lead to new ways of diagnosing MASH easily and accurately, which is important because diagnosing it early can help prevent further liver damage. Who this helps: This helps patients with liver disease by providing a less invasive diagnostic option.

Plain English
This study explored a set of biomarkers called TLM3 to see if they can help predict the early development of liver fibrosis in people at risk for fatty liver disease (MASLD). Researchers found that levels of a specific protein called IGFBP7 in the blood could reliably predict new liver fibrosis after seven years in study participants who had lower levels initially. This is important because identifying liver damage early can lead to better treatment options and potentially lower the risk of serious health problems. Who this helps: This benefits patients at risk for fatty liver disease and their doctors by providing a way to detect early liver damage.

Plain English
This study looked at how the gut bacteria in cancer patients can affect muscle loss, a condition known as cancer cachexia. Researchers found that patients with cancer tend to have fewer beneficial bacteria that produce short-chain fatty acids (SCFAs), which help maintain muscle and reduce inflammation. By increasing these good bacteria and decreasing harmful bacteria, they aim to slow down muscle loss and improve overall health; for instance, restoring SCFAs can help reduce the entry of harmful substances into the bloodstream. Who this helps: This benefits cancer patients experiencing muscle loss and their healthcare providers.

Plain English
This study looked at specific substances in the blood and urine of people with nondiabetic chronic kidney disease (CKD) to see if they could predict the disease. Researchers analyzed samples from 124 people with nondiabetic CKD, 45 with diabetic kidney disease (DKD), and 200 healthy individuals. They found that substances in urine were better at predicting nondiabetic CKD, particularly certain lipids, while blood samples showed different amino acids as significant indicators; importantly, most findings related to nondiabetic CKD could also apply to DKD. Who this helps: This research benefits both patients with chronic kidney disease and doctors by providing better tools for early detection and understanding of kidney health.

Plain English
This study focused on measuring levels of proinsulin and C-peptide in 482 individuals with long-term type 1 diabetes to better understand how these markers relate to the health of insulin-producing cells in the body. The researchers found that while proinsulin levels decreased over the first 15 years after diagnosis, they stabilized afterward, with higher levels linked to certain antibodies in the blood. This is important because it shows that proinsulin can still be present, indicating that some insulin-producing cells may still be functioning even a long time after diabetes onset. Who this helps: This research benefits patients with type 1 diabetes by providing insights into their long-term insulin production.

Plain English
This study looked at a new tool called SMEAR that helps analyze gut bacteria by using images of stool samples. It accurately identified the presence of certain types of bacteria and overall diversity in fecal samples from 888 individuals, with high accuracy rates over 80%. This is important because it offers a quick and cost-effective way to monitor gut health, which can have significant implications for understanding various health conditions. Who this helps: This benefits patients and healthcare providers by providing an easier way to monitor gut health.

Plain English
This study looks at how gut bacteria influence the levels of a substance called methylglyoxal (MGO) in our bodies, which is linked to issues like inflammation and chronic diseases, especially those related to diabetes and heart problems. Researchers suggest that gut microbes can either create or break down MGO, and changes in diet may affect these bacteria, potentially improving health. This matters because finding ways to manage MGO through gut health could help reduce the risks of serious conditions like diabetes and heart disease. Who this helps: Patients with diabetes or cardiovascular issues.

Plain English
This study looked at the levels of a harmful compound called methylglyoxal (MGO) and its relationship to liver damage in severely obese people, particularly those with metabolic issues. Researchers found that higher MGO levels were linked to more severe liver fibrosis, with MGO levels averaging 288 nmol/L in those with type 2 diabetes compared to 238 nmol/L in those without. These findings suggest that monitoring and targeting MGO could be important for treating liver damage in obese patients. Who this helps: This helps patients with obesity and liver disease, as well as doctors treating these conditions.

Plain English
This study looked at the effects of a treatment called duodenal mucosal resurfacing (DMR) combined with a medication called liraglutide on people with type 2 diabetes, focusing on how these treatments help control blood sugar long-term. After four years, 64% of the participants were no longer using insulin, but only 36% of the total group had good blood sugar control. While patients were satisfied with the DMR procedure and many were open to having it again, the overall effectiveness in controlling blood sugar seemed to decrease over time. Who this helps: This helps patients with type 2 diabetes who are looking for alternatives to insulin.

Plain English
This study looked at how certain gut bacteria that produce a substance called butyrate can help protect against bacterial pneumonia. In experiments with mice, those that received butyrate treatment before being infected showed reduced bacterial growth, less organ damage, and decreased inflammation. In humans, patients with higher levels of butyrate-producing bacteria had lower inflammation markers and better recovery from pneumonia, suggesting that these bacteria could be beneficial. Who this helps: This helps patients with pneumonia and may benefit doctors looking for new treatments.

Plain English
This study looked at how gut bacteria and their byproducts, short-chain fatty acids (SCFAs), might affect the way certain parts of the brain connect when at rest. Researchers compared healthy individuals with very high and very low levels of SCFA production and found no differences in brain connectivity between these groups. This is important because it challenges the idea that SCFAs directly influence brain areas related to reward and appetite, suggesting other factors from gut bacteria might be involved in appetite control. Who this helps: This information benefits researchers and healthcare professionals studying obesity and appetite regulation.

Plain English
This study looked at how the bacteria in our gut, known as the gut microbiome, affect our health as we age and how they relate to diseases like obesity. Researchers found that changes in these gut bacteria are linked to various metabolic issues, which can lead to problems such as obesity and age-related diseases. For example, obesity is connected to a decrease in gut bacteria diversity, impacting how our bodies manage energy and inflammation. Understanding these relationships is important because it can lead to new ways to treat or prevent health problems related to aging and metabolism. Who this helps: This research benefits patients dealing with obesity and age-related health issues.

Plain English
This study looked at how well patients absorb energy and fat after two different weight loss surgeries: Roux-en-Y gastric bypass (RYGB) and sleeve gastrectomy (SG). Researchers found that patients who had RYGB experienced more malabsorption, with an average of 194.8 calories (13.2%) and 9.7 grams (15.4%) of fat being lost, compared to 111.7 calories (7.6%) and 3.9 grams (6.1%) in those who had SG. This research is important because it helps doctors understand the differences in absorption between these two surgeries, which can affect patient outcomes. Who this helps: This helps patients considering weight loss surgery and their doctors in making informed decisions.

Plain English
This study looked at a protein called beta-klotho (KLB) in healthy human tissues and liver samples from patients with a liver disease known as metabolic dysfunction-associated steatotic liver disease (MASLD). Researchers found that KLB is present in various organs, including the liver and pancreas, and that lower levels of KLB in the liver were connected to more inflammation in the liver tissue. This is important because it shows that KLB is still available as a target for certain liver disease treatments, even in advanced stages of MASLD. Who this helps: Patients with MASLD and doctors treating this condition.

Plain English
This study looks at how the gut microbiome, the collection of bacteria in our intestines, affects a liver disease called metabolic dysfunction-associated steatotic liver disease (MASLD). Researchers found that certain gut bacteria can turn sugars from our diet into ethanol, which can worsen the liver's condition. Importantly, by improving gut health through diet or probiotics, we might reduce the harmful effects of this ethanol and improve liver health. Who this helps: This helps patients with MASLD and healthcare providers managing their treatment.

Plain English
This study looked at how certain substances in the blood, known as metabolites, relate to blood pressure in a group of 369 people from different ethnic backgrounds, including Dutch, Ghanaian, and South-Asian. Researchers found that a specific metabolite called N-formylmethionine (fMet) was linked to higher blood pressure, showing an increase of about 4.14 mmHg in systolic (the top number) and 2.61 mmHg in diastolic (the bottom number) pressure for every unit increase in fMet. This is important because it helps us understand a new way that high blood pressure can develop, especially in diverse populations, which may lead to better prevention and treatment strategies. Who this helps: This helps patients at risk for high blood pressure and their doctors in identifying new treatment options.

Plain English
This study looked at whether taking capsules made from a person's own gut bacteria could help maintain insulin-producing cells in people with type 1 diabetes. Researchers found that while participants' beta-cell function dropped significantly during a 3-month pre-treatment phase, it did not decline during the 3 months of taking the capsules or the 3 months after that. No serious side effects were noted, although more people experienced constipation during the treatment. Who this helps: Patients with type 1 diabetes.

Plain English
This study looked at how fecal microbiota transplantation (FMT) might improve cancer treatment outcomes and reduce side effects in cancer patients. Researchers reviewed 45 studies and found that while FMT was mostly safe and could help manage issues like colitis during cancer treatment, there wasn't enough strong evidence yet to say it worked effectively for improving overall treatment results. Understanding how FMT influences cancer treatment can help create better strategies for using it in different patients. Who this helps: This helps cancer patients undergoing various treatments.

Plain English
This study looked at how a combination of a specific supplement called ARHAM and inositol could affect weight gain and metabolism in mice fed a high-fat diet. After 13 weeks, mice that received this combination gained less weight compared to those who only got inositol or no treatment. The findings are significant because they suggest that this combination might help improve metabolism and reduce weight gain in the context of obesity and diabetes. Who this helps: This benefits researchers and healthcare providers looking for new treatments for obesity and type 2 diabetes.

Plain English
This study looked at how doctors define and assess two toe problems: claw toe and hammertoe. Researchers found that there are 16 different definitions for hammertoe and 11 for claw toe, which leads to confusion since many doctors have different ways of describing and measuring these conditions. Because most evaluations rely heavily on simply observing the toes rather than standardized methods, it makes it harder for doctors to communicate and understand these deformities effectively. Who this helps: This helps doctors and patients by improving clarity in diagnosing and treating toe deformities.

Plain English
This study looked at how safe and effective acupuncture is for children aged 6 to 18 who suffer from functional constipation, a common issue that often doesn't improve with usual treatments like laxatives. They enrolled children for eight acupuncture sessions over 10 weeks, aiming for at least a 70% retention rate. The researchers will measure various outcomes, such as if children still meet the criteria for constipation, how often they go to the bathroom, and their overall quality of life. Who this helps: This helps children suffering from functional constipation and their families.

Plain English
This research paper looks at Type 1 Diabetes (T1D), an autoimmune disease where the immune system destroys insulin-producing cells in the pancreas. The study highlights the role of gut bacteria and their byproducts in influencing the immune system and explores new treatments that could help preserve these insulin-producing cells. Promising approaches include therapies that adjust immune cell activity and methods targeting gut bacteria, which could slow the disease's progression in upcoming clinical studies. Who this helps: This benefits patients with Type 1 Diabetes and their healthcare providers.

Plain English
This study looks at whether taking an 8-week supplement of tributyrin, a substance related to butyrate, is practical and acceptable for people with depression who are also on antidepressant medications. It involves 24 participants who will take 4 grams of tributyrin each day, and researchers will track changes in their depression symptoms and overall well-being. If successful, this research could lead to new treatment options that help improve mental health by focusing on the connection between the gut and the brain. Who this helps: This helps patients with depression seeking additional treatment options.

Plain English
This study looked at how changes in gut bacteria (microbiota) can affect cancer cachexia, a condition that causes serious weight loss and muscle wasting in cancer patients. Researchers found that these bacterial changes may ignite inflammation and disrupt metabolism, making cancer treatment less effective. By exploring new treatments that target gut bacteria, like probiotics and fecal transplants, the study aims to improve the care and outcomes for patients experiencing cachexia. Who this helps: Patients dealing with cancer and cachexia.

Plain English
This study looks at how two apps designed for parents can help reduce the use of antibiotics for children with common respiratory infections and improve their gut health. Researchers are testing a FeverApp that gives advice on managing fever and an NMP WebApp that helps parents use natural remedies safely. They aim to see if using these apps leads to fewer antibiotic prescriptions and fewer doctor visits, and the study involves 320 parents who will track their child's health over ten days. Who this helps: This research benefits parents of young children with fever and respiratory infections.

Plain English
This study looked at a new treatment for patients with type 2 diabetes that combines an endoscopic procedure called Re-cellularization via electroporation therapy (ReCET) with a medication called semaglutide. After two years, 100% of the patients who initially stopped insulin remained off it and maintained good blood sugar levels, with no serious side effects reported. This is significant because it offers a potential long-term solution that not only eliminates the need for insulin but also improves overall metabolic health. Who this helps: This helps patients with type 2 diabetes looking for alternatives to insulin treatment.

Plain English
This study looked at how a diet high in sugar but lacking fat affects liver fat production and growth in mice, focusing on the role of gut bacteria. It found that mice eating this sugar-rich diet gained significant fat in their livers, with an increase in fat-related gene activity, while the presence of gut bacteria was crucial for this fat development. Understanding this process is important because it sheds light on how sugar consumption can lead to liver problems, even without fat in the diet. Who this helps: This helps patients at risk for liver disease due to high sugar diets.